Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2236581

CN(Cc1ccc(CN2CCCC2)cc1)C(=O)c1coc(CN(C2CC2)S(=O)(=O)c2ccccc2C(F)(F)F)n1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.40
CXCR4 P61073 2/20 0.38
SLC2A1 P11166 2/20 0.37
BDKRB1 P46663 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35
KCNH2 Q12809 2/20 0.34
RAB9A P51151 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12347158 0.97 RORC (0.41) RORCCXCR4BDKRB1KDM4EMEN1
Trifluoroacetic Acid SCHEMBL2240072 0.86 SLC2A1 (0.35) CXCR4SLC2A1NPSR1PKMHTT
Trifluoroacetic Acid SCHEMBL2237264 0.85 HTT (0.35) RORCCXCR4SLC2A1KDM4EMEN1
Trifluoroacetic Acid SCHEMBL2236586 0.85 HTT (0.36) RORCCXCR4SLC2A1KDM4EMEN1
SCHEMBL12347130 0.81 EP300 (0.36) CXCR4BDKRB1PKMHTTSMN1; SMN2
SCHEMBL12347119 0.80 EP300 (0.37) RORCCXCR4KDM4EMEN1KMT2A
SCHEMBL12347146 0.80 HTT (0.37) RORCCXCR4KDM4EMEN1KMT2A
SCHEMBL1935711 0.78 RORC (0.43) RORCMEN1KMT2AMAPK1RAB9A
SCHEMBL2239968 0.78 EP300 (0.41) CXCR4BDKRB1KMT2A
Trifluoroacetic Acid SCHEMBL2237433 0.78 BDKRB1 (0.51) RORCBDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140073627-A1 BRADYKININ B1 ANTAGONISTS EVOTEC AG (DE) 2014-03-13 US claimed
US-20110201589-A1 NEW BRADYKININ B1 ANTAGONISTS EVOTEC AG (DE) 2011-08-18 US claimed
US-20140073627-A1 BRADYKININ B1 ANTAGONISTS EVOTEC AG (DE) 2014-03-13 US disclosed
US-8623859-B2 Bradykinin B1 antagonists EVOTEC AG (DE) 2014-01-07 US disclosed
US-20110201589-A1 NEW BRADYKININ B1 ANTAGONISTS EVOTEC AG (DE) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073627-A1 BRADYKININ B1 ANTAGONISTS BDKRB1, BDKRB2, BRS3 RORC 4444/4885CXCR4 220/4885SLC2A1 4158/4885
US-20110201589-A1 NEW BRADYKININ B1 ANTAGONISTS BDKRB1, BDKRB2, BRS3 RORC 4539/4885CXCR4 210/4885SLC2A1 4142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.